Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 2791 AL 2805

Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies

Moore KBE, Hung TJ, Fortin JS.

Drug Discov Today. 2023 Mar;28(3):103487. doi: 10.1016/j.drudis.2023.103487. Epub 2023 Jan 9.

TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer's disease treatment

Ayyubova G.

Eur J Neurosci. 2023 Feb;57(4):718-733. doi: 10.1111/ejn.15914. Epub 2023 Jan 29.

Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases

Abd-Nikfarjam B, Dolati-Somarin A, Baradaran Rahimi V, Askari VR.

Biofactors. 2023 May-Jun;49(3):560-583. doi: 10.1002/biof.1936. Epub 2023 Jan 13.

Estrogen signaling via estrogen receptor alpha and its implications for neurodegeneration associated with Alzheimer's disease in aging women

Tecalco-Cruz AC, López-Canovas L, Azuara-Liceaga E.

Metab Brain Dis. 2023 Mar;38(3):783-793. doi: 10.1007/s11011-023-01161-2. Epub 2023 Jan 14.

Structural fingerprinting of pleiotropic flavonoids for multifaceted Alzheimer's disease

Punmiya A, Prabhu A.

Neurochem Int. 2023 Feb;163:105486. doi: 10.1016/j.neuint.2023.105486. Epub 2023 Jan 11.

Programmed Death of Microglia in Alzheimer's Disease: Autophagy, Ferroptosis, and Pyroptosis

Qiu Z, Zhang H, Xia M, Gu J, Guo K, Wang H, Miao C.

J Prev Alzheimers Dis. 2023;10(1):95-103. doi: 10.14283/jpad.2023.3.

Embryo Selection for a Carrier of an Early-Onset Alzheimer's Disease-Associated Mutation in the PSEN1 Gene

Valdés-Martínez OH, García-Luna SM, Oceguera-Palao LC, Villarreal-Pineda L, Sordia-Hernández LH, de la Fuente Cortez B, Morales-Martínez A.

J Prev Alzheimers Dis. 2023;10(1):144-147. doi: 10.14283/jpad.2023.4.

Exosomes: A missing link between chronic systemic inflammation and Alzheimer's disease?

Ozansoy M, Mikati H, Velioglu HA, Yulug B.

Biomed Pharmacother. 2023 Mar;159:114161. doi: 10.1016/j.biopha.2022.114161. Epub 2023 Jan 13.

The foundation and architecture of precision medicine in neurology and psychiatry

Hampel H, Gao P, Cummings J, Toschi N, Thompson PM, Hu Y, Cho M, Vergallo A.

Trends Neurosci. 2023 Mar;46(3):176-198. doi: 10.1016/j.tins.2022.12.004. Epub 2023 Jan 13.

The Impact of the Cellular Environment and Aging on Modeling Alzheimer's Disease in 3D Cell Culture Models

Hebisch M, Klostermeier S, Wolf K, Boccaccini AR, Wolf SE, Tanzi RE, Kim DY.

Adv Sci (Weinh). 2023 Mar;10(8):e2205037. doi: 10.1002/advs.202205037. Epub 2023 Jan 15.

Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?

Rodriguez-Jimenez FJ, Ureña-Peralta J, Jendelova P, Erceg S.

J Adv Res. 2023 Dec;54:105-118. doi: 10.1016/j.jare.2023.01.006. Epub 2023 Jan 14.

Role of angiotensin receptor blockers in the context of Alzheimer's disease

Kuber B, Fadnavis M, Chatterjee B.

Fundam Clin Pharmacol. 2023 Jun;37(3):429-445. doi: 10.1111/fcp.12872. Epub 2023 Jan 26.

Oral THC: CBD cannabis extract in main symptoms of Alzheimer disease: agitation and weight loss

Palmieri B, Vadalà M.

Clin Ter. 2023 Jan-Feb;174(1):53-60. doi: 10.7417/CT.2023.5009.

Cellular Stress Response (Hormesis) in Response to Bioactive Nutraceuticals with Relevance to Alzheimer Disease

Butterfield DA, Boyd-Kimball D, Reed TT.

Antioxid Redox Signal. 2023 Mar;38(7-9):643-669. doi: 10.1089/ars.2022.0214.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias